Palatin Technologies, Inc. (LON:0KF3)
London · Delayed Price · Currency is GBP · Price in USD 15.50
+1.53 (10.95%)
May 28, 2026, 4:21 PM GMT
Palatin Technologies Market Cap
Palatin Technologies has a market cap or net worth of 18.93 million as of May 28, 2026. Its market cap has decreased by -11.62% in one year.
Market Cap
18.93M
Enterprise Value
11.58M
Revenue
9.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.50
Market Cap Chart
Since January 29, 2018, Palatin Technologies's market cap has decreased from 124.07M to 18.93M, a decrease of -84.74%. That is a compound annual growth rate of -20.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 18.93M | -46.16% |
| Dec 11, 2025 | 35.16M | 61.85% |
| Dec 31, 2024 | 21.72M | -43.72% |
| Dec 29, 2023 | 38.60M | 99.29% |
| Dec 28, 2022 | 19.37M | -79.00% |
| Dec 30, 2021 | 92.25M | -28.03% |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Poolbeg Pharma | 39.13M |
| Sareum Holdings | 33.26M |
| ImmuPharma | 26.86M |
| SkinBioTherapeutics | 25.14M |
| Arecor Therapeutics | 24.92M |
| Aptamer Group | 19.87M |
| IXICO | 19.08M |
| Fusion Antibodies | 16.25M |